ClinicalTrials.Veeva

Menu

Establishment of Human Lung Stem Cell Proliferation System and Organoid Construction in COPD

C

China-Japan Friendship Hospital

Status

Enrolling

Conditions

Chronic Obstructive Pulmonary Disease

Study type

Observational

Funder types

Other

Identifiers

NCT06275230
ZRJY2021-BJ08-02-07

Details and patient eligibility

About

The goal of this study is to proliferate human lung stem cell in vitro in order to establish a lung organoid derived from patients with COPD. The main question it aims to answer are:

  • Can human lung stem cell proliferate in vitro.
  • Can a lung organoid derived from patients with COPD be established. Participants will be sampled during pulmonary bronchoscope for organoid establishment.

Enrollment

30 estimated patients

Sex

All

Ages

18 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

    1. Age under 55, regardless of gender
    1. Patients with COPD lung disease who are going to undergo bronchoscopic biopsy
    1. No genetic diseases and other respiratory diseases

Exclusion criteria

  • Other conditions determined by the investigators to be unsuitable for inclusion, such as difficult sampling, difficult follow-up, and complicated with other serious diseases

Trial design

30 participants in 1 patient group

chronic obstructive pulmonary disease
Description:
Patients with COPD undergoing bronchoscope.

Trial contacts and locations

1

Loading...

Central trial contact

Mingming Deng, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems